Taconic has entered into an agreement to market and distribute proprietary knockout rat models, produced by Transposagen Biopharmaceuticals (Transposagen). The agreement expands the line of models Taconic offers to investigators and complements the company's custom and off-the-shelf models.
Subscribe to our email newsletter
As per the deal, Taconic gains worldwide rights to distribute a selection of Transposagen’s TKO Knockout Rat Models, developed using advanced mobile DNA technologies. The rat repository currently includes approximately 100 models. Transposagen has expressed plans to expand it to 30,000 lines, eventually providing a knockout for each gene in the rat genome.
Kevin Leak, senior vice president of client relations at Taconic, said: “The addition of Transposagen’s knockout rat repository to Taconic’s portfolio of transgenic models further strengthens our ability to provide a broad range of sophisticated tools to investigators engaged in pharmaceutical and biomedical research.
“We are excited to offer more options for the many researchers who turn to Taconic as their preferred source for transgenic models, custom models, and supporting services.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.